Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergy diagnosis (8)
  • Asthma (13)
  • Basic immunology (1)
  • Biologicals (10)
  • Biomarkers (6)
  • COVID19 (1)
  • Dermatology (6)
  • x Drug allergy (9)
  • ENT (5)
  • Pediatrics (1)
Poster available until
  • Until platform closure (6)
Poster categories
  • Thematic Poster Session (7)
keywords
Session Reference
  • L-TPS01 (6)
  • L-TPS02 (1)
  • L-TPS05 (12)
  • L-TPS07 (1)
  • L-TPS12 (11)
  • L-TPS13 (4)
  • L-TPS14 (6)
  • L-TPS15 (2)
  • TPS02 (1)
  • TPS03 (3)
  • TPS11 (13)
  • TPS12 (12)
  • TPS14 (2)
  • TPS28 (3)
  • TPS31 (3)
  • TPS36 (12)
  • TPS37 (3)
  • TPS38 (6)
  • TPS52 (5)
  • x TPS53 (6)
  • TPS54 (15)
  • x TPS55 (3)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (7)
  • TPS67 (1)
  • TPS69 (1)
9 results
Thumbnail

D3.34 - Cephalosporine drug provocation in a population of children with confirmed serum sickness-like reaction to amoxicillin

Thumbnail

D3.35 - Severe atopic dermatitis poorly controlled, or something else?

Thumbnail

D3.37 - Beware of the Rare: AGEP

Thumbnail

D3.42 - Symmetrical drug-related intertriginous and flexural exanthema related to symptomatic slow-acting drug for osteoarthritis (SYSADOA) – a case report

Thumbnail

D3.44 - The Role of Medical History and Diagnostic Testing in Identifying Post-Surgical Allergic Reactions

Thumbnail

D3.45 - Perioperative Immediate Hypersensitivity Reactions: First Chilean Cohort Study 2020-2024 Clinical Hospital University of Chile

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

D3.109 - Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis

Thumbnail

- D3.110 - Contribution of biotherapies in the reintroduction of NSAIDs in patients with moderate to severe asthma, hypersensitive to COX-1 inhibitor NSAIDs

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM